Filters

Pp-151 manufacturers

Filters

1 products found

pp-151

Solution for injection

Dossier type
CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA
Comments
Indication: Alexander disease (AxD) — rare leukodystrophy caused by gain-of-function GFAP mutations Clinical stage: Phase 3 Modality: Oligonucleotide (antisense oligonucleotide, intrathecal) Mechanism / Target: Targets and silences GFAP mRNA in CNS astrocytes — reduces mutant GFAP protein accumulation (Rosenthal fibres) that causes astrocyte dysfunction and neurodegeneration Route / form: Intrathecal injection (periodic dosing) Differentiation: Only clinical-stage disease-modifying therapy for Alexander disease; directly addresses pathological GFAP accumulation; Ionis CNS ASO platform with established intrathecal delivery
Manufacturer #39180

Leader in RNA-targeting therapeutics with multiple approved antisense drugs. Develops GalNAc-conjugated ASOs for precise liver-targeted gene silencing in cardiometabolic and rare diseases. Wholly owned commercial and late-stage pipeline with independent global development.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.